Decentralized CoordinationFederationmedium
Open LAAC outcomes registry
A clinician-governed, patient-consented registry could publish standardized WATCHMAN and competing left atrial appendage closure outcomes, complications, operator experience, device identifiers, and follow-up data through auditable open data schemas.
Thesis
The concept does not replace the implant on day one; it weakens the incumbent information advantage by making real-world safety, efficacy, and site-level performance easier to compare outside vendor-controlled materials.
Bitcoin / decentralization role
Federated clinical registries let hospitals, physicians, researchers, and patient groups maintain local governance while sharing interoperable outcome data. Decentralization matters because no single manufacturer should control the evidence surface for implanted devices.
Coordination mechanism
Hospitals and registries submit standardized procedure and follow-up records; patients consent to data use; independent clinical stewards define schemas and publish aggregate analyses; payers and procurement groups use the evidence in coverage and purchasing decisions.
Verification / trust model
Records would be tied to hospital attestations, device identifiers, audit trails, and periodic third-party validation against medical records or claims data. Public aggregate statistics reduce selective disclosure, while privacy-preserving publication limits patient re-identification risk.
Failure modes
- • Hospitals may resist sharing performance data that exposes site-level variation.
- • Vendor influence, inconsistent coding, and incomplete follow-up could bias the registry unless governance and audits are strong.
Adoption path
- • Start with voluntary academic and high-volume centers publishing a common LAAC outcomes dataset.
- • Expand through payer, society, and procurement pressure until registry participation becomes a credibility signal for devices and procedure programs.
Decentralization fit
58.0/10
The registry decentralizes evidence and oversight rather than device manufacturing, which is realistic for an implantable therapy.
Coordination credibility
64.0/10
Hospitals, payers, physicians, and patients already have incentives to understand real-world outcomes, but shared governance and privacy controls are hard.
Implementation feasibility
52.0/10
Data infrastructure and clinical registry models are feasible, but standardization, consent, auditing, and participation incentives would take sustained institutional work.
Incumbent pressure
44.0/10
Transparent outcomes could pressure pricing and claims, though it would not directly manufacture a substitute LAAC implant.